Calvin Krogh

Calvin Krogh currently serves as Associate Director of New Product Planning at Intellia Therapeutics, Inc., following a successful tenure as Senior Manager in the same department. Prior experience includes a role as Associate Principal at IQVIA, where notable achievements encompassed securing $30 million in funding for a global CRM platform and leading initiatives that generated over $2 million in client engagements within regenerative medicine. Additional positions included operational analysis at Dana-Farber Cancer Institute and consulting roles across various organizations, utilizing an MBA and MPH from Boston University to deliver impactful strategies in healthcare management and market access. Calvin Krogh holds a B.A. in Religious Studies from the University of Chicago.